Breakthrough Achievement: Tuodao Medical's Tuoling® Robotic-Assisted Laparoscopic System Successfully Completes First High-Difficulty Urological Clinical Trial
Tuodao Medical
Surgical Robot Developer
On March 5, Tuoling, independently developed by Tuodao Medical®The endoscopic surgical robot was officially launched at Jiangsu Province Hospital (the First Affiliated Hospital of Nanjing Medical University) and successfully completed the enrollment of the first patient in a urology clinical trial.At Tuodao®Under the assistance of an endoscopic surgical robot, Professor Wang Zengjun, Director of the Department of Urology at our hospital, completed a trial of robot-assisted laparoscopic partial nephrectomy., which signifies another important clinical advancement for domestically produced laparoscopic surgical robots, marking a significant milestone for Tuodao Medical in the field of laparoscopic surgical robotics.
Swipe left or right to view more
This surgery was performed on a 73-year-old male patient with a mass in the left kidney. After thorough discussion, Professor Wang Zengjun’s team decided to use Tuodao Medical’s Tuoling system.®Robotic-Assisted Laparoscopic Partial Nephrectomy. Intraoperatively, under high-definition 3D visualization, the supervising surgeon identified multiple renal lesions and a complex clinical presentation: due to the patient’s obesity, saponification of the perirenal fat made dissection particularly challenging; the lesions were located deep within the renal parenchyma and were completely endophytic, posing significant difficulty for nephron-sparing surgery. Given the patient’s chronic renal insufficiency and strong preoperative desire to undergo kidney-preserving surgery to slow the progression of renal dysfunction, Professor Wang Zengjun’s team, after extensive discussions, utilized intraoperative ultrasound to localize the tumors. Leveraging the dexterity of the robotic instruments, they precisely resected the lesions, ultimately preserving the patient’s kidney.Intraoperative blood loss was less than 15 mL, significantly superior to that of conventional laparoscopic surgery, and the patient’s vital signs remained stable postoperatively.
Swipe left or right to view more
Tuoling®The endoscopic surgical robot consists of a surgeon console, a patient-side surgical platform, and an image processing platform. Compared with traditional endoscopy, Tuoling®The 8-degree-of-freedom control arms of the laparoscopic surgical robot provide surgeons with an exceptionally dexterous operational experience. The proprietary 3D electronic endoscope delivers three-dimensional stereoscopic images with rich depth-of-field information, offering surgeons meticulous and immersive visual feedback. High-precision master-slave control algorithms empower surgeons to perform delicate maneuvers with ease, enabling minimally invasive and precise resection of lesions. The intelligent human-machine interaction design simplifies user operations through automated features such as one-click positioning, thereby enhancing surgical efficiency. A comprehensive suite of 15 types of instruments meets the routine clinical and customized needs across various medical departments.
Professor Wang Zengjun
M.D., Chief Physician, Professor, and Doctoral Supervisor; Director of the Department of Urology, Jiangsu Province Hospital (The First Affiliated Hospital of Nanjing Medical University); Director of the Jiangsu Human Sperm Bank; Leader of the National Key Clinical Specialty and the Jiangsu “Science and Education Strengthening Health Project” Key Medical Discipline; Head of the Jiangsu Provincial Urology Diagnosis and Treatment Center.
Postoperatively, Professor Wang Zengjun evaluated Tuoling®Evaluation of the Laparoscopic Surgical Robot: Today's case isOne in a HundredThe difficulty exceeded preoperative predictions, posing significant surgical challenges;Tuoling®The robotic system demonstrated exceptional stability throughout the entire procedure, facilitating the successful completion of the surgery and exceeding the surgeon’s expectations.Tuoling®It meets the precise operational requirements of various urological surgical procedures, offering safer and more efficient therapeutic advantages, particularly for high-difficulty surgeries. The minimal surgical incisions and reduced intraoperative bleeding facilitate patients’ rapid and optimal recovery. It is gratifying to witness the rapid development of domestic brands. We are confident that, driven by the ever-evolving R&D capabilities of “Intelligent Manufacturing in China” and the extensive clinical experience of Chinese surgeons, next-generation surgical robotics companies represented by Tuodao Medical will continue to innovate and scale new heights!
Embarking on a New Journey Today, Tuodao Medical Integrates Laparoscopic Surgery with Next-Generation AI Technology to Truly Simplify Surgical Procedures. Recently, Tuoling®The laparoscopic surgical robot will launch comprehensive multi-center clinical trials across multiple departments—including urology, hepatobiliary surgery, gastrointestinal surgery, gynecology, and thoracic surgery—at numerous hospitals nationwide in China, accelerating its regulatory approval and market launch to bring this advanced technology to patients as soon as possible.
About Tuodao Medical
Tuodao Medical specializes in the design, research and development, and clinical implementation of surgical robots. It is committed to providing robotic solutions for medical users across all specialties, empowering the development of the smart healthcare industry through technological innovation.
Leveraging cutting-edge core technologies such as data algorithms, artificial intelligence, and precision intelligent control, Tuodao Medical has meticulously developed a core technological platform for surgical robots. The company has strategically laid out its presence in five major surgical robot sectors: orthopedics, endoscopy, percutaneous puncture, natural orifice transluminal surgery, and medical imaging equipment. By deeply cultivating diverse clinical departments and procedural applications, Tuodao Medical’s surgical robot product pipeline now covers orthopedics, general surgery, gynecology, urology, pulmonology, and radiology.
In the future, upholding its corporate mission of “Making Surgery Simpler, Making Life Healthier,” Tuodao Medical will collaborate with industry and ecosystem partners to achieve a comprehensive product portfolio layout, build an integrated remote smart healthcare center, and jointly shape the future of human health.
2022, Tuodao Medical's Tuo Hand®Orthopedic surgical robots and Daoying mobile C-arm X-ray machines have been approved for market launch; in 2023, Daoying 3D mobile C-arm X-ray machines and Tuoying®Mobile C-arm X-ray Machine and Tuodao Surgery®Percutaneous Puncture Surgical Robot Obtains Certification and Achieves Commercialization. In 2024, the Core Product Tuoling®Laparoscopic surgical robots have officially entered human clinical trials. We believe that AI-empowered healthcare will benefit a vast number of patients and promote healthier lives.